483
Haleon US Inc.Haleon US Inc. – FDA 483, Sep 30, 2021
Record Details
An FDA inspection of GSK Consumer Health Inc. in Lincoln, NE, revealed significant deficiencies in quality control and manufacturing processes. The firm failed to thoroughly review out-of-specification materials and packaging defects, leading to distributed products with potential quality issues. Additionally, there were inadequate written procedures for the quality control unit, equipment cleaning, microbial control in water systems, and the drug product stability program.
View Company Profile
ID · 62f851a1-563f-4ffc-a4ec-eb6f8d67e1b3
Other documents for Haleon US Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.